Harris Associates’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-538,760
Closed -$23.8M 133
2020
Q3
$23.8M Sell
538,760
-60,191
-10% -$2.65M 0.06% 105
2020
Q2
$25.3M Sell
598,951
-567
-0.1% -$21.8K 0.06% 105
2020
Q1
$23.8M Sell
599,518
-4,832
-0.8% -$204K 0.07% 101
2019
Q4
$26.9M Sell
604,350
-2,398
-0.4% -$92.2K 0.05% 105
2019
Q3
$20.8M Sell
606,748
-6,483
-1% -$224K 0.04% 107
2019
Q2
$23.1M Buy
613,231
+9,652
+2% +$330K 0.04% 106
2019
Q1
$18.4M Buy
603,579
+90,073
+18% +$2.75M 0.03% 107
2018
Q4
$14.2M Buy
+513,506
New +$14.1M 0.03% 105

Other funds holding ACA

Harris Associates's ACA Position: Q4 2020 in Review

Harris Associates sold out of Arcosa (ACA) in Q4 2020, closing a stake of 538,760 shares — an estimated $23.8M sold.

Harris Associates first reported a position in ACA in Q4 2018 and held it in 8 quarters. The position peaked at $26.9M in Q4 2019. 269 funds tracked by Wall St. Rank hold ACA as of Q4 2020.

  • Harris Associates reported no remaining Arcosa position as of Q4 2020 after selling out during the quarter.
  • Harris Associates sold 538,760 Arcosa shares in Q4 2020, an estimated $23.8M.
  • Harris Associates first reported a position in Arcosa in Q4 2018 and held it in 8 quarters.
  • Harris Associates's Arcosa position peaked at $26.9M in Q4 2019.
  • 269 funds tracked by Wall St. Rank held Arcosa as of Q4 2020.

Based on Harris Associates's 13F filing for Q4 2020, filed 16 Feb 2021.